TY - JOUR
T1 - Corrigendum
T2 - A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke (Frontiers in Molecular Biosciences, (2021), 8, (611367), 10.3389/fmolb.2021.611367)
AU - Eyford, Brett A.
AU - Singh, Chaahat S.B.
AU - Abraham, Thomas
AU - Munro, Lonna
AU - Choi, Kyung Bok
AU - Hill, Tracy
AU - Hildebrandt, Rhonda
AU - Welch, Ian
AU - Vitalis, Timothy Z.
AU - Gabathuler, Reinhard
AU - Gordon, Jacob A.
AU - Adomat, Hans
AU - Guns, Emma S.T.
AU - Lu, Chieh Ju
AU - Pfeifer, Cheryl G.
AU - Tian, Mei Mei
AU - Jefferies, Wilfred A.
N1 - Funding Information:
In the original article, there was an error in the Funding statement. “MT” should be removed from “BTI MT.” The corrected Funding statement should read: “Funding for this work was provided to WJ in the Michael Smith Laboratories, at the University of British Columbia and the Vancouver Prostate Centre, at Vancouver General Hospital, by a grant from the Canadian Institutes for Health Research (MOP-133635), a grant from the Natural Sciences and Engineering Research Council of Canada (CRDPJ 452456–13) in collaboration with Bioasis Technologies Inc. (BTI, meimei@bioasis.us), a grant from the W. Garfield Weston Foundation (RR161038), and donations from the Sullivan Urology Foundation at Vancouver General Hospital. TA was supported by NIH grants 1S10OD010756–01A1 and 1S10OD018124– 01A1. BE was supported by Postdoctoral Fellowships from the Michael Smith Foundation for Health Research, the Centre for Blood Research at the University of British Columbia and the Pacific Alzheimer’s Foundation. CS was supported by an Alzheimer’s Drug Discovery Foundation Outstanding Young Investigator Scholarship, and by a William and Dorothy Gilbert Graduate
Publisher Copyright:
Copyright © 2021 Eyford, Singh, Abraham, Munro, Choi, Hill, Hildebrandt, Welch, Vitalis, Gabathuler, Gordon, Adomat, Guns, Lu, Pfeifer, Tian and Jefferies
PY - 2021/5/7
Y1 - 2021/5/7
N2 - In the original article, there was an error in the Funding statement. “MT” should be removed from “BTI MT.” The corrected Funding statement should read: “Funding for this work was provided to WJ in the Michael Smith Laboratories, at the University of British Columbia and the Vancouver Prostate Centre, at Vancouver General Hospital, by a grant from the Canadian Institutes for Health Research (MOP-133635), a grant from the Natural Sciences and Engineering Research Council of Canada (CRDPJ 452456–13) in collaboration with Bioasis Technologies Inc. (BTI, meimei@bioasis.us), a grant from the W. Garfield Weston Foundation (RR161038), and donations from the Sullivan Urology Foundation at Vancouver General Hospital. TA was supported by NIH grants 1S10OD010756–01A1 and 1S10OD018124– 01A1. BE was supported by Postdoctoral Fellowships from the Michael Smith Foundation for Health Research, the Centre for Blood Research at the University of British Columbia and the Pacific Alzheimer’s Foundation. CS was supported by an Alzheimer’s Drug Discovery Foundation Outstanding Young Investigator Scholarship, and by a William and Dorothy Gilbert Graduate Scholarship in Biomedical Sciences at the University of British Columbia and a scholarship from the Centre for Blood Research Graduate Student Award at the University of British Columbia.” Additionally, there was a mistake in the COI section, which should now read: “The authors declare that this study received funding from Bioasis Technologies Inc. The funder did not influence the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.” The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
AB - In the original article, there was an error in the Funding statement. “MT” should be removed from “BTI MT.” The corrected Funding statement should read: “Funding for this work was provided to WJ in the Michael Smith Laboratories, at the University of British Columbia and the Vancouver Prostate Centre, at Vancouver General Hospital, by a grant from the Canadian Institutes for Health Research (MOP-133635), a grant from the Natural Sciences and Engineering Research Council of Canada (CRDPJ 452456–13) in collaboration with Bioasis Technologies Inc. (BTI, meimei@bioasis.us), a grant from the W. Garfield Weston Foundation (RR161038), and donations from the Sullivan Urology Foundation at Vancouver General Hospital. TA was supported by NIH grants 1S10OD010756–01A1 and 1S10OD018124– 01A1. BE was supported by Postdoctoral Fellowships from the Michael Smith Foundation for Health Research, the Centre for Blood Research at the University of British Columbia and the Pacific Alzheimer’s Foundation. CS was supported by an Alzheimer’s Drug Discovery Foundation Outstanding Young Investigator Scholarship, and by a William and Dorothy Gilbert Graduate Scholarship in Biomedical Sciences at the University of British Columbia and a scholarship from the Centre for Blood Research Graduate Student Award at the University of British Columbia.” Additionally, there was a mistake in the COI section, which should now read: “The authors declare that this study received funding from Bioasis Technologies Inc. The funder did not influence the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.” The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
UR - http://www.scopus.com/inward/record.url?scp=85106159709&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106159709&partnerID=8YFLogxK
U2 - 10.3389/fmolb.2021.687587
DO - 10.3389/fmolb.2021.687587
M3 - Comment/debate
C2 - 34026851
AN - SCOPUS:85106159709
SN - 2296-889X
VL - 8
JO - Frontiers in Molecular Biosciences
JF - Frontiers in Molecular Biosciences
M1 - 687587
ER -